Brief: Egetis Therapeutics Carries Out Directed Share Issue
Oct 3 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST: SAID ON THURSDAY CO HAS SUCCESSFULLY CARRIED OUT A DIRECTED SHARE ISSUE AMOUNTING TO SEK 183 MLN SUBSCRIPTION PRICE OF SEK 5.10 PER SHARE Source text for Workspace: nMFN94b42R Further company coverage: EGTX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1